Full Name
Go Mei Lin
Variants
Mei, L.
Mei Lin, G.
Go M.-L.
Go, M.-L.
Go, M.I.
Go, M.L.
Mei, L.G.
Go, Mei Lin
Mei Lin Go
Go, M.
 
Main Affiliation
 
Faculty
 
Email
phagoml@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2000 TO 3000]

Results 21-40 of 82 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
212005Chalcones: An update on cytotoxic and chemoprotective propertiesGo, M.L. ; Wu, X.; Liu, X.L.
22Sep-2012Curcumin Analogues with Potent and Selective Anti-proliferative Activity on Acute Promyelocytic Leukemia: Involvement of Accumulated Misfolded Nuclear Receptor Co-repressor (N-CoR) Protein as a Basis for Selective ActivityTan, K.-L.; Koh, S.-B.; Ee, R.P.-L. ; Khan, M. ; Go, M.-L. 
232018Curcuminoids as EBV lytic activators for adjuvant treatment in EBV-positive carcinomasRamayanti, O; Brinkkemper, M; Verkuijlen, S.A.W.M; Ritmaleni, L; Go, M.L ; Middeldorp, J.M
24Nov-2010Determination of Z-3,5,4'-trimethoxystilbene in rat plasma by a simple HPLC method: Application in a pre-clinical pharmacokinetic studyLin, H.-S. ; Zhang, W.; Go, M.L. ; Choo, Q.-Y.; Ho, P.C. 
252015Determining the functions of HIV-1 Tat and a second magnesium ion in the CDK9/cyclin T1 complex: A molecular dynamics simulation studyJin, Haixiao; Go, Mei Lin ; Yin, Peng; Qiu, Xiaoting; Zhu, Peng; Yan, Xiaojun
2615-Nov-2008Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)Sim, H.-M.; Lee, C.-Y. ; Ee, P.L.R. ; Go, M.-L. 
278-Sep-2020Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic ComplicationsOng, Wei-Yi ; Go, Mei-Lin ; Wang, De-Yun ; Cheah, Irwin Kee-Mun ; Halliwell, Barry 
2830-Jul-2002Effects of pH on the stability and compressibility of DPPC/cholesterol monolayers at the air-water interfaceGong, K.; Feng, S.-S. ; Go, M.L. ; Soew, P.H.
2915-Mar-2004Erratum: Structure-activity relationships of antileishmanial and antimalarial chalcones (Bioorganic and Medicinal Chemistry (2003) 11 (2729-2738) DOI: 101016S0968089603002335)Liu, M.; Wilairat, P.; Croft, S.L.; Tan, A.L.-C. ; Go, M.-L. 
30Jun-2012Exploration and Optimization of Structure-Activity Relationships in Drug Design using the Taguchi MethodYeo, W.K. ; Tan, K.L.; Koh, S.B.; Khan, M. ; Nilar, S.; Go, M.L. 
318-Sep-2011Exploring aigialomycin D and its analogues as protein kinase inhibitors for cancer targetsXu, J.; Chen, A.; Go, M.-L. ; Nacro, K.; Liu, B.; Chai, C.L.L. 
32May-2012Exploring the Anticancer Activity of Functionalized Isoindigos: Synthesis, Drug-like Potential, Mode of Action and Effect on Tumor-Induced XenograftsWee, X.K.; Yang, T.; Go, M.L. 
332020Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”Yam, Y.-K.; Alvarez, N.; Go, M.-L. ; Dick, T.
341-Mar-2009Functionalized 3-benzylidene-indolin-2-ones: Inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activityZhang, W.; Go, M.-L. 
351-Apr-2014Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical speciesNguyen, T.; Yang, T.; Go, M.-L. 
36Jul-2010Functionalized aurones as inducers of NAD(P)H:quinone oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: Synthesis, evaluation and SARLee, C.-Y. ; Chew, E.-H. ; Go, M.-L. 
371-Jan-2008Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance proteinLiu, X.-L.; Tee, H.-W.; Go, M.-L. 
38Aug-2008Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureusLiu, X.L.; Xu, Y.J.; Go, M.L. 
3911-Nov-2021Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosisFridianto, Kevin T; Li, Ming ; Hards, Kiel; Negatu, Dereje A; Cook, Gregory M; Dick, Thomas ; Lam, Yulin ; Go, Mei-Lin 
402013Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt)Ramanujulu, P.M.; Yang, T.; Yap, S.-Q.; Wong, F.-C.; Casey, P.J. ; Wang, M. ; Go, M.-L.